Sharply Institute, the R&D centre of Poly, is fully equipped with state-of-the-art instruments and other facilities such as libraries, research databases. In the laboratory with an area of 3000 square meters, 200 scientists devote themselves to innovation in generic medicines, especially through developing new formulations including: Controlled Release, Taste Masking and Injectable of insoluble API.